These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6252992)

  • 1. Regulation of platelet arachidonic acid oxygenation by cyclic AMP.
    Schafer AI; Levine S; Handin RI
    Blood; 1980 Nov; 56(5):853-8. PubMed ID: 6252992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
    Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
    J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic AMP and platelet prostaglandin synthesis.
    Gerrard JM; Peller JD; Krick TP; White JG
    Prostaglandins; 1977 Jul; 14(1):39-50. PubMed ID: 197570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory role of cyclic adenosine 3',5'-monophosphate on the platelet cyclooxygenase and platelet function.
    Fitzpatrick FA; Gorman RR
    Biochim Biophys Acta; 1979 Jan; 582(1):44-58. PubMed ID: 216415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triphenyltin fluoride in vitro inhibition of rabbit platelet collagen-induced aggregation and ATP secretion and blockade of arachidonic acid mobilization from membrane phospholipids.
    Manabe S; Wada O; Matsui H; Takada M; Kobayashi N; Maekawa T
    Biochem Pharmacol; 1983 May; 32(10):1627-34. PubMed ID: 6305366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW
    Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the mechanism of the inhibition of platelet aggregation and release induced by high levels of arachidonate.
    Linder BL; Goodman DS
    Blood; 1982 Aug; 60(2):436-45. PubMed ID: 6284285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
    Romstedt K; Huzoor-Akbar
    Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid.
    Vargaftig BB; Chignard M
    Agents Actions; 1975 May; 5(2):137-44. PubMed ID: 51579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets.
    Rao AK; Koike K; Day HJ; Smith JB; Holmsen H
    Am J Clin Pathol; 1985 Jun; 83(6):687-96. PubMed ID: 3923822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
    Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
    Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.
    Remuzzi G; Benigni A; Dodesini P; Schieppati A; Livio M; De Gaetano G; Day SS; Smith WL; Pinca E; Patrignani P; Patrono C
    J Clin Invest; 1983 Mar; 71(3):762-8. PubMed ID: 6298281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.
    Needleman P; Raz A; Minkes MS; Ferrendelli JA; Sprecher H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):944-8. PubMed ID: 218223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
    Maguire MH; Csonka-Khalifah L
    Biochim Biophys Acta; 1987 Oct; 921(3):426-36. PubMed ID: 3117116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
    Kowalska MA; Rao AK; Disa J
    Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The activation by Ca2+ of platelet phospholipase A2. Effects of dibutyryl cyclic adenosine monophosphate and 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate.
    Rittenhouse-Simmons S; Deykin D
    Biochim Biophys Acta; 1978 Nov; 543(4):409-22. PubMed ID: 214141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effects of exogenous arachidonic acid on rabbit platelet aggregation and the release reaction.
    Cattaneo M; Kinlough-Rathbone RL; Perry DW; Chahil A; Vickers JD; Lam SC; Packham MA; Mustard JF
    Blood; 1982 Nov; 60(5):1179-87. PubMed ID: 6289942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of acetylsalicylate on aggregation and arachidonate metabolism by human platelets suspended in plasma or buffer.
    McDonald-Gibson WJ; McDonald-Gibson RG; Power GM; Collier HO
    Prostaglandins Leukot Med; 1984 Jul; 15(1):1-14. PubMed ID: 6433360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of albumin and calcium on human platelet arachidonic acid metabolism.
    Stuart MJ; Gerrard JM; White JG
    Blood; 1980 Mar; 55(3):418-23. PubMed ID: 6766753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.